Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cronos Australia Ltd. (AU:VIT)
ASX:VIT
Cronos Australia Ltd. (VIT) Share Price & Analysis
6 Followers
VIT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.13 - AU$0.58
Previous CloseAU$0.16
Volume49.50K
Average Volume (3M)259.85K
Market Cap
AU$97.90M
Enterprise ValueAU$86.85M
Total Cash (Recent Filing)AU$16.08M
Total Debt (Recent Filing)AU$5.06M
Price to Earnings (P/E)9.5
Beta-0.15
Next Earnings
Aug 28, 2024EPS EstimateN/A
Last Dividend Ex-Date
Sep 04, 2023Dividend Yield5.88%
Share Statistics
EPS (TTM)0.02
Shares OutstandingN/A
10 Day Avg. Volume105,028
30 Day Avg. Volume259,845
Standard Deviation0.21
R-Squared0.42
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.24Price Target Upside50.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cronos Australia Ltd. News
PremiumCompany Announcements
Vitura Health Announces Final Share Release from Escrow
PremiumCompany Announcements
Vitura Health Launches Local MDMA ProductionOptions Prices
Currently, No data available
---
Ownership Overview
46.24% Insiders
<0.01% Mutual Funds
0.00% Other Institutional Investors
53.76% Public Companies and
Individual Investors
VIT FAQ
What was Cronos Australia Ltd.’s price range in the past 12 months?
Cronos Australia Ltd. lowest share price was AU$0.13 and its highest was AU$0.58 in the past 12 months.
What is Cronos Australia Ltd.’s market cap?
Currently, no data Available
When is Cronos Australia Ltd.’s upcoming earnings report date?
Cronos Australia Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 109 days.
How were Cronos Australia Ltd.’s earnings last quarter?
Cronos Australia Ltd. released its earnings results on Feb 26, 2024. The company reported AU$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.006.
Is Cronos Australia Ltd. overvalued?
According to Wall Street analysts Cronos Australia Ltd.’s price is currently Undervalued.
Does Cronos Australia Ltd. pay dividends?
Cronos Australia Ltd. pays a Annually dividend of <AU$0.01 which represents an annual dividend yield of 5.88%. See more information on Cronos Australia Ltd. dividends here
What is Cronos Australia Ltd.’s EPS estimate?
Cronos Australia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cronos Australia Ltd. have?
Cronos Australia Ltd. has 575,873,800 shares outstanding.
What happened to Cronos Australia Ltd.’s price movement after its last earnings report?
Cronos Australia Ltd. reported an EPS of AU$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cronos Australia Ltd.?
Currently, no hedge funds are holding shares in AU:VIT
---
Cronos Australia Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.24 (50.00% Upside)
AU$0.24 (50.00% Upside)
Blogger Sentiment
Bullish
AU:VIT Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.25%
12-Months-Change
Fundamentals
Return on Equity
27.73%
Trailing 12-Months
Asset Growth
48.56%
Trailing 12-Months
Company Description
Cronos Australia Ltd.
Cronos Australia Ltd operates in the healthcare industry. The firm is a medicinal cannabis company engaged in offering both THC and CBD products. It carries on the activity of brand development, outsourced manufacturing and distribution for Australia, and export markets. The company has three operating segments: Medical, Clinics and Consumer. Medical involves the sale of medicinal cannabis products, Clinics involves the operation of medicinal cannabis products, the Consumer segment carries on the sale of consumer products. Substantial revenue comes from the sale of medicinal cannabis products. The firm has two geographical segments; Asia and Australia of which it drives maximum revenue from Australia.
---
VIT Stock 12 Month Forecast
Average Price Target
AU$0.24
▲(50.00% Upside)
Technical Analysis
Recce Pharmaceuticals Ltd.
―
EVE Health Group Limited
―
Little Green Pharma Ltd.
―
Best Analysts Covering VIT
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-33.78%
reiterated a buy rating 8 months ago
Copying Anubhav Saxena's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -33.78% per trade.
---